As principal investigator and director of the UAMS Translational Research Institute (TRI) and associate vice chancellor for Clinical and Translational Research, Laura James, M.D., is responsible for the institute’s overall administration and strategic development. She currently serves as the co-chair of the National Center for Advancing Translational Sciences Clinical and Translational Science Awards Program Steering Committee and is a board member of the Association for Clinical and Translational Science.
James is a professor of pediatrics at the UAMS College of Medicine and a faculty member in the Division of Clinical Pharmacology and Toxicology within the Section of Emergency Medicine at Arkansas Children’s Hospital.
She has extensive experience in clinical and translational research in NIH-supported research networks. Her research program in acetaminophen toxicity has been funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) since 1999. In 2006, she co-founded Acetaminophen Toxicity Diagnostics (ATD) LLC, to develop a novel laboratory test, AcetaSTAT, to rapidly detect acetaminophen toxicity. The Small Business Technology Transfer program of NIDDK funds this research.
